Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication

(MedPage Today) — FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial.
In its premarket approval application for the Ventura Interatrial Shunt…

Source link : https://www.medpagetoday.com/cardiology/chf/118788

Author :

Publish date : 2025-12-02 17:41:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication

Polypharmacy Is a Real Issue. Dismantling Public Health Won’t Fix It.

Delaying Hep B Vaccine in Infants Carries Significant Risks, Report Warns

Related Posts

MRI Sans Biopsy Not Ready for Prime Time in Active Surveillance for Prostate Cancer

Republican Senator Demands More Answers From AMA on Its Billing Code Business

New Antiobesity Drugs Eagerly Anticipated

Doctors Have a Front-Row Seat to the Caregiver Crisis

Novel Alzheimer’s Pill May Slow Decline in Some High-Risk Patients

GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids

MRI Sans Biopsy Not Ready for Prime Time in Active Surveillance for Prostate Cancer

Republican Senator Demands More Answers From AMA on Its Billing Code Business

New Antiobesity Drugs Eagerly Anticipated

Doctors Have a Front-Row Seat to the Caregiver Crisis

Novel Alzheimer’s Pill May Slow Decline in Some High-Risk Patients

GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids

Standard-of-Care Treatment for Rheumatoid Arthritis Lags for Minority Groups

Cardiologist Heads New ACIP; Distal Access Catheter Recall; Another Lipid Marker?

Categories

Archives